Correction {#Sec1}
==========

Since publication of this article \[[@CR1]\], the authors have noted three inaccuracies in their report which they would like to amend. The details of these, and the appropriate corrections are detailed below:The Placebo group bars in Figure two (Figure [1](#Fig1){ref-type="fig"} here) were incorrect. The corrected version of this figure can be seen in Figure [1](#Fig1){ref-type="fig"}. This correction does not alter the results or interpretation.At the beginning of the discussion, it was stated that the TMT-B time score showed an improvement of 68% after 3 months. This value is incorrect, as the correct value is 18%. While, this change is large it does not change the interpretation or other discussion points.In the Methods section Intervention and Randomization on page 3, the amount of daily vitamin D delivered from the Catalyn should be 416 IU/day, not 312 IU/day. This has no consequences on the results, but improves accuracy of study design reporting.Figure 1**The CONSORT flowchart.**

The online version of the original article can be found at 10.1186/1472-6882-14-43
